Bristol-Myers Squibb Co. (BMY) Misses Q4 EPS by 2c, Sales Fall Just Short
Tweet
Share
E-mailGet Alerts BMY Hot Sheet
Price: $64.83 +1.77%
Financial Fact:
Other (income)/expense: -224M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Other (income)/expense: -224M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Bristol-Myers Squibb Co. (NYSE: BMY) reported Q4 EPS of $0.53, $0.02 worse than the analyst estimate of $0.55. Revenue for the quarter came in at $5.45 billion versus the consensus estimate of $5.5 billion.
For earnings history and earnings-related data on Bristol-Myers Squibb Co. (BMY) click here.
For earnings history and earnings-related data on Bristol-Myers Squibb Co. (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Cantor Fitzgerald Reiterates Overweight Rating on Global Net Lease (GNL)
- Axos Financial (AX) PT Raised to $120 at Benchmark
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
